Pacific Biosciences of California Inc (PACB)
1.55
+0.09
(+6.16%)
USD |
NASDAQ |
Apr 19, 16:00
1.54
-0.01
(-0.65%)
After-Hours: 17:04
Pacific Biosciences of California Gross Profit Margin (Quarterly): 16.40% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.40% |
| September 30, 2023 | 32.15% |
| June 30, 2023 | 32.68% |
| March 31, 2023 | 25.09% |
| December 31, 2022 | 18.79% |
| September 30, 2022 | 41.93% |
| June 30, 2022 | 45.66% |
| March 31, 2022 | 42.67% |
| December 31, 2021 | 46.55% |
| September 30, 2021 | 44.04% |
| June 30, 2021 | 44.93% |
| March 31, 2021 | 44.75% |
| December 31, 2020 | 42.01% |
| September 30, 2020 | 37.02% |
| June 30, 2020 | 38.72% |
| March 31, 2020 | 48.01% |
| December 31, 2019 | 46.30% |
| September 30, 2019 | 31.55% |
| June 30, 2019 | 39.04% |
| March 31, 2019 | 31.15% |
| December 31, 2018 | 29.43% |
| September 30, 2018 | 17.58% |
| June 30, 2018 | 41.07% |
| March 31, 2018 | 37.68% |
| December 31, 2017 | 38.08% |
| Date | Value |
|---|---|
| September 30, 2017 | 34.94% |
| June 30, 2017 | 39.86% |
| March 31, 2017 | 35.87% |
| December 31, 2016 | 44.22% |
| September 30, 2016 | 50.31% |
| June 30, 2016 | 51.30% |
| March 31, 2016 | 49.69% |
| December 31, 2015 | 72.95% |
| September 30, 2015 | 47.07% |
| June 30, 2015 | 58.17% |
| March 31, 2015 | 33.59% |
| December 31, 2014 | 26.25% |
| September 30, 2014 | 63.82% |
| June 30, 2014 | 27.36% |
| March 31, 2014 | 22.99% |
| December 31, 2013 | 34.92% |
| September 30, 2013 | 16.72% |
| June 30, 2013 | 17.51% |
| March 31, 2013 | 16.67% |
| December 31, 2012 | 10.67% |
| September 30, 2012 | 6.84% |
| June 30, 2012 | 3.77% |
| March 31, 2012 | -1.51% |
| December 31, 2011 | 12.35% |
| September 30, 2011 | 31.64% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
16.40%
Minimum
Dec 2023
48.01%
Maximum
Mar 2020
37.80%
Average
41.93%
Median
Sep 2022
Gross Profit Margin (Quarterly) Benchmarks
| Integer Holdings Corp | 26.69% |
| Cerus Corp | 55.51% |
| Axogen Inc | 78.66% |
| AVITA Medical Inc | 87.35% |
| Intellia Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -45.62% |
| Return on Assets | -16.75% |
| Return on Invested Capital | -19.58% |
| Profit Margin (Quarterly) | -140.5% |
| Operating Margin (Quarterly) | -148.0% |
| Return on Net Operating Assets | -28.73% |